TERIFLUNOMIDE
Generic: TERIFLUNOMIDE
Glenmark Pharmaceuticals Inc.Manufacturer
ORALRoute
TERIFLUNOMIDEActive Substance
2018-11-15Original Approval
TERIFLUNOMIDE is FDA application ANDA209663, sponsored by GLENMARK SPECLT. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
FATIGUE
845 reports
2
ALOPECIA
835 reports
3
DIARRHOEA
779 reports
4
MULTIPLE SCLEROSIS RELAPSE
665 reports
5
HYPOAESTHESIA
609 reports
6
FALL
576 reports
7
HEADACHE
558 reports
8
CONDITION AGGRAVATED
544 reports
9
GAIT DISTURBANCE
518 reports
10
PARAESTHESIA
518 reports